This site is intended for Healthcare professionals only.

Alembic Pharma gets EIR for Karakhadi facility


Alembic Pharma gets EIR for Karakhadi facility

New Delhi: Drug firm Alembic Pharmaceuticals said it has received establishment inspection report (EIR) from the US health regulator for its Karakhadi facility in Gujarat.

The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection carried out at the active pharmaceutical ingredient facility at Karakhadi from May 14-18, 2018, Alembic Pharmaceuticals said in a BSE filing.

“With this, all our manufacturing facilities for international markets are FDA compliant,” it added.

An establishment inspection report is given by the US health regulator USFDA on the closure of inspection of an establishment.



Source: PTI
0 comment(s) on Alembic Pharma gets EIR for Karakhadi facility

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted